TNM staging with FDG-PET/CT in patients with primary head and neck cancer. (Q53467189)

14 May 2018

title

TNM staging with FDG-PET/CT in patients with primary head and neck cancer. (English)

1 reference

14 May 2018

8

Andreas Bockisch

1 reference

14 May 2018

Gerald Antoch

10

object named as

Gerald Antoch

1 reference

14 May 2018

author name string

Patrick Veit-Haibach

1

1 reference

14 May 2018

Christopher Luczak

2

1 reference

14 May 2018

Isabel Wanke

3

1 reference

14 May 2018

Markus Fischer

4

1 reference

14 May 2018

Thomas Egelhof

5

1 reference

14 May 2018

Thomas Beyer

6

1 reference

14 May 2018

Gerlinde Dahmen

7

1 reference

14 May 2018

Sandra Rosenbaum

9

1 reference

14 May 2018

publication date

24 August 2007

1 reference

14 May 2018

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

14 May 2018

volume

34

1 reference

14 May 2018

issue

12

1 reference

14 May 2018

page(s)

1953-1962

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1007/s00259-007-0564-5

exact match

0 references

cites work

The impact of FDG PET on the management of occult primary head and neck tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0564-5

Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0564-5

Enlarged cervical lymph nodes at helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0564-5

The spiral CT of cervical lymph node enlargements. The initial clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0564-5

18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

21 January 2018

1 reference

12 December 2020

Unknown primary tumors: detection with dual-modality PET/CT--initial experience

1 reference

12 December 2020

18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

1 reference

12 December 2020

Cancer statistics, 2005

1 reference

12 December 2020

Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.

1 reference

12 December 2020

Normal FDG distribution patterns in the head and neck: PET/CT evaluation.

1 reference

12 December 2020

Head and neck lesions. Radiologic-pathologic correlations

1 reference

12 December 2020

Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer

1 reference

12 December 2020

The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma.

1 reference

12 December 2020

Equivalence test and confidence interval for the difference in proportions for the paired-sample design.

1 reference

12 December 2020

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Iterative threshold segmentation for PET target volume delineation.

1 reference

12 December 2020

Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology.

1 reference

12 December 2020

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

12 December 2020

Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.

1 reference

12 December 2020

A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma

1 reference

12 December 2020

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

12 December 2020

Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer

1 reference

12 December 2020

Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images

1 reference

12 December 2020

Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation

1 reference

12 December 2020

Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting

1 reference

12 December 2020

On the use of positioning aids to reduce misregistration in the head and neck in whole-body PET/CT studies.

1 reference

12 December 2020

Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT.

1 reference

12 December 2020

Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging

1 reference

12 December 2020

Positron emission imaging of head and neck cancer, including thyroid carcinoma

1 reference

12 December 2020

Head and neck malignancy: is PET/CT more accurate than PET or CT alone?

1 reference

12 December 2020

PET/CT in the evaluation of patients with squamous cell cancer of the head and neck.

1 reference

12 December 2020

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

1 reference

12 December 2020

18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer

1 reference

12 December 2020

10.1007/S00259-007-0564-5

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

17717661

1 reference

14 May 2018